Search

Your search keyword '"McKinstry DN"' showing total 30 results

Search Constraints

Start Over You searched for: Author "McKinstry DN" Remove constraint Author: "McKinstry DN"
30 results on '"McKinstry DN"'

Search Results

2. Orally active angiotensin-converting enzyme inhibitor (SO 14,225) as a treatment for essential hypertension.

3. beta-Adrenoceptor-blocking agents and the kidney: effect of nadolol and propranolol on the renal circulation.

5. Identification and determination of the S-methyl metabolite of captopril in human plasma by selected-ion monitoring gas chromatography-mass spectrometry.

6. Renal handling of captopril: effect of probenecid.

7. Determination of total captopril in human plasma by gas chromatography-mass spectrometry with selected-ion monitoring after reduction of disulfides.

8. Captopril: pharmacology, metabolism and disposition.

9. Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man.

10. Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis.

11. Multiple-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects.

12. Pharmacokinetics of captopril in healthy subjects and in patients with cardiovascular diseases.

13. Hemodynamic and antihypertensive effects of captopril, an orally active angiotensin converting enzyme inhibitor.

14. Disposition of captopril in normal subjects.

15. Captopril kinetics.

16. Comparison of kinetic interactions of nadolol and propranolol with cimetidine.

17. Long-term treatment of hypertension in man by an orally active angiotensin-converting enzyme inhibitor.

18. Pharmacokinetics of captopril in elderly healthy male volunteers.

19. Oral angiotensin-converting enzyme inhibitor in long-term treatment of hypertensive patients.

20. Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients.

21. Effect of food on the bioavailability of captopril in healthy subjects.

22. Pharmacokinetics of iodamide in normal subjects and in patients with renal impairment.

24. A specific orally active inhibitor of angiotensin-converting enzyme in man.

26. Effects of drugs on acetylcholine release from the cat superior cervical ganglion by carbachol and by preganglionic stimulation.

27. Acetylcholine release from the cat superior cervical ganglion by carbachol.

30. 5-Benzoyl-1-methylpyrrole-2-acetic acids as antiinflammatory agents.

Catalog

Books, media, physical & digital resources